We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
An image displaying a Newsletter on tablet, laptop & mobile

To continue reading this article, sign up for FREE to

Technology Networks logo


Membership is FREE and provides you with instant access to email newsletters, digital publications, our full content catalogue & more...

Wyeth Renews and Expands License Agreement with Ingenuity Systems

Read time: Less than a minute

Ingenuity Systems has announced that it has entered an agreement with Wyeth to extend and expand its licensing agreement for access to IPA software.

Wyeth's research and development teams will utilize IPA in multiple research areas, including its pharmacogenomics group that focuses on approaches to identifying biomarkers.

"We are pleased that Wyeth has selected Ingenuity Systems as a key partner for its research programs," said Peter DiLaura, Senior Vice President of Commercial Operations at Ingenuity.

"Wyeth has been a valued customer since 2003, and we view this renewal as a testament to our ability to provide relevant and valuable solutions for researchers who need to analyze and understand the biological and chemical relationships within their experimental systems," DiLaura continued.

IPA is a software and content solution that provides insights and understanding of complex biological and chemical systems at the core of life science research.